首页 > 最新文献

Human Antibodies最新文献

英文 中文
Serostatus of Coxsackie B in a sample of women with miscarriage in Baghdad, Iraq. 伊拉克巴格达流产妇女样本中柯萨奇 B 的血清状态。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/HAB-240005
Mervet B Jasim, Asmaa B Al-Obaidi, Enas Adnan Abdulrasul, Haider Faisal Ghazi

Background: The antibody that crosses transplacentally from mother to fetus is very important origin of protective passive immunity against infection neonatal with enterovirus. Important varieties of coxsackievirus B3 (CVB3) are responsible for infections in newborns. The purpose from this study is to investigate in the prevalence of Coxsackie B virus in a sample of Iraqi women with miscarriage and potential role of miscarriage risk.

Methods: Between November 2022 and June 2023, we included 91 parturient women (gestational age: 4-20 weeks) who were between the ages of 15 and 40. Every participant completed a questionnaire, and blood was drawn to assess maternal antibodies against CVB3.

Results: The blood seropositive rates were 46 out 91(50.54%), 2 out 46 were IgM positive (4.34%), (8-12 weeks) 23 from 46 (50%) (p-value 0.0294) gestational age more frequent among aborted women that positive for anti-coxsackie B antibody, The 25-35 age group was significantly overrepresented (51/91, 56%) compared to other age groups.

Conclusion: This investigation posits Coxsackie B virus (CBV) as a possible etiology for miscarriage in the Iraqi female population. Further studies employing larger cohorts and robust methodologies, beyond the current detection technique, are warranted to corroborate these observations and elucidate the potential mechanisms by which CBV might induce miscarriage.

导言:经胎盘从母体传给胎儿的抗体是新生儿感染肠道病毒后产生保护性被动免疫的重要来源。柯萨奇病毒 B3(CVB3)是导致新生儿感染的重要病毒。本研究的目的是调查柯萨奇 B 病毒在伊拉克流产妇女样本中的流行情况以及对流产风险的潜在作用:方法:在 2022 年 11 月至 2023 年 6 月期间,我们纳入了 91 名年龄在 15 岁至 40 岁之间的流产妇女(孕龄:4-20 周)。每位参与者都填写了一份调查问卷,并抽血评估母体的 CVB3 抗体:结果:血清阳性率为 91 人中的 46 人(50.54%),46 人中有 2 人 IgM 阳性(4.34%),(8-12 周)46 人中有 23 人(50%)(P 值为 0.0294),胎龄越大,抗柯萨奇 B 抗体阳性的流产妇女越多,与其他年龄组相比,25-35 岁年龄组的比例明显偏高(51/91,56%):这项调查认为柯萨奇 B 病毒(CBV)可能是伊拉克女性流产的病因之一。除了目前的检测技术外,还需要采用更大的群体和更可靠的方法进行进一步研究,以证实这些观察结果,并阐明 CBV 可能诱发流产的潜在机制。
{"title":"Serostatus of Coxsackie B in a sample of women with miscarriage in Baghdad, Iraq.","authors":"Mervet B Jasim, Asmaa B Al-Obaidi, Enas Adnan Abdulrasul, Haider Faisal Ghazi","doi":"10.3233/HAB-240005","DOIUrl":"10.3233/HAB-240005","url":null,"abstract":"<p><strong>Background: </strong>The antibody that crosses transplacentally from mother to fetus is very important origin of protective passive immunity against infection neonatal with enterovirus. Important varieties of coxsackievirus B3 (CVB3) are responsible for infections in newborns. The purpose from this study is to investigate in the prevalence of Coxsackie B virus in a sample of Iraqi women with miscarriage and potential role of miscarriage risk.</p><p><strong>Methods: </strong>Between November 2022 and June 2023, we included 91 parturient women (gestational age: 4-20 weeks) who were between the ages of 15 and 40. Every participant completed a questionnaire, and blood was drawn to assess maternal antibodies against CVB3.</p><p><strong>Results: </strong>The blood seropositive rates were 46 out 91(50.54%), 2 out 46 were IgM positive (4.34%), (8-12 weeks) 23 from 46 (50%) (p-value 0.0294) gestational age more frequent among aborted women that positive for anti-coxsackie B antibody, The 25-35 age group was significantly overrepresented (51/91, 56%) compared to other age groups.</p><p><strong>Conclusion: </strong>This investigation posits Coxsackie B virus (CBV) as a possible etiology for miscarriage in the Iraqi female population. Further studies employing larger cohorts and robust methodologies, beyond the current detection technique, are warranted to corroborate these observations and elucidate the potential mechanisms by which CBV might induce miscarriage.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":" ","pages":"61-65"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Free radicals and oxidative stress: Mechanisms and therapeutic targets. 自由基和氧化应激:机制与治疗目标:评论文章。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/HAB-240011
Huda A Hassan, Hind Sh Ahmed, Dheefaf F Hassan

Background: Free radicals are small extremely reactive species that have unpaired electrons. Free radicals include subgroups of reactive species, which are all a product of regular cellular metabolism. Oxidative stress happens when the free radicals production exceeds the capacity of the antioxidant system in the body's cells.

Objective: The current review clarifies the prospective role of antioxidants in the inhibition and healing of diseases.

Methods: Information on oxidative stress, free radicals, reactive oxidant species, and natural and synthetic antioxidants was obtained by searching electronic databases like PubMed, Web of Science, and Science Direct, with articles published between 1987 and 2023 being included in this review.

Results: Free radicals exhibit a dual role in living systems. They are toxic byproducts of aerobic metabolism that lead to oxidative injury and tissue disorders and act as signals to activate appropriate stress responses. Endogenous and exogenous sources of reactive oxygen species are discussed in this review. Oxidative stress is a component of numerous diseases, including diabetes mellitus, atherosclerosis, cardiovascular disease, Alzheimer's disease, Parkinson's disease, and cancer. Although various small molecules assessed as antioxidants have shown therapeutic prospects in preclinical studies, clinical trial outcomes have been inadequate. Understanding the mechanisms through which antioxidants act, where, and when they are active may reveal a rational approach that leads to more tremendous pharmacological success. This review studies the associations between oxidative stress, redox signaling, and disease, the mechanisms through which oxidative stress can donate to pathology, the antioxidant defenses, the limits of their effectiveness, and antioxidant defenses that can be increased through physiological signaling, dietary constituents, and probable pharmaceutical interference. Prospective clinical applications of enzyme mimics and current progress in metal- and non-metal-based materials with enzyme-like activities and protection against chronic diseases have been discussed.

Conclusion: This review discussed oxidative stress as one of the main causes of illnesses, as well as antioxidant systems and their defense mechanisms that can be useful in inhibiting these diseases. Thus, the positive and deleterious effects of antioxidant molecules used to lessen oxidative stress in numerous human diseases are discussed. The optimal level of vitamins and minerals is the amount that achieves the best feed benefit, best growth rate, and health, including immune efficiency, and provides sufficient amounts to the body.

背景:自由基是具有未成对电子的极高活性小分子物质。自由基包括活性物质亚群,它们都是细胞正常新陈代谢的产物。当自由基的产生超过人体细胞抗氧化系统的能力时,就会出现氧化应激:本综述阐明了抗氧化剂在抑制和治疗疾病方面的前瞻性作用:方法:通过搜索PubMed、Web of Science和Science Direct等电子数据库,获取有关氧化应激、自由基、活性氧化物种以及天然和合成抗氧化剂的信息,并将1987年至2023年间发表的文章纳入本综述:自由基在生命系统中具有双重作用。它们是有氧代谢的有毒副产物,会导致氧化损伤和组织失调,同时也是激活适当应激反应的信号。本综述将讨论活性氧的内源性和外源性来源。氧化应激是许多疾病的组成部分,包括糖尿病、动脉粥样硬化、心血管疾病、阿尔茨海默病、帕金森病和癌症。虽然各种被评估为抗氧化剂的小分子在临床前研究中显示出了治疗前景,但临床试验结果却不尽如人意。了解抗氧化剂的作用机制、作用部位和作用时间可能会发现一种合理的方法,从而取得更大的药理成功。这篇综述研究了氧化应激、氧化还原信号转导和疾病之间的关联,氧化应激导致病变的机制,抗氧化剂的防御能力、其有效性的极限,以及通过生理信号转导、饮食成分和可能的药物干扰可以提高的抗氧化剂防御能力。此外,还讨论了酶模拟物的临床应用前景,以及具有类似酶活性的金属和非金属材料在预防慢性疾病方面的最新进展:本综述讨论了作为疾病主要原因之一的氧化应激,以及可用于抑制这些疾病的抗氧化系统及其防御机制。因此,本文讨论了抗氧化剂分子用于减轻氧化应激对多种人类疾病的积极和有害影响。维生素和矿物质的最佳含量是指能达到最佳饲料效益、最佳生长速度和健康(包括免疫效率),并能为机体提供足够量的维生素和矿物质。
{"title":"Free radicals and oxidative stress: Mechanisms and therapeutic targets.","authors":"Huda A Hassan, Hind Sh Ahmed, Dheefaf F Hassan","doi":"10.3233/HAB-240011","DOIUrl":"10.3233/HAB-240011","url":null,"abstract":"<p><strong>Background: </strong>Free radicals are small extremely reactive species that have unpaired electrons. Free radicals include subgroups of reactive species, which are all a product of regular cellular metabolism. Oxidative stress happens when the free radicals production exceeds the capacity of the antioxidant system in the body's cells.</p><p><strong>Objective: </strong>The current review clarifies the prospective role of antioxidants in the inhibition and healing of diseases.</p><p><strong>Methods: </strong>Information on oxidative stress, free radicals, reactive oxidant species, and natural and synthetic antioxidants was obtained by searching electronic databases like PubMed, Web of Science, and Science Direct, with articles published between 1987 and 2023 being included in this review.</p><p><strong>Results: </strong>Free radicals exhibit a dual role in living systems. They are toxic byproducts of aerobic metabolism that lead to oxidative injury and tissue disorders and act as signals to activate appropriate stress responses. Endogenous and exogenous sources of reactive oxygen species are discussed in this review. Oxidative stress is a component of numerous diseases, including diabetes mellitus, atherosclerosis, cardiovascular disease, Alzheimer's disease, Parkinson's disease, and cancer. Although various small molecules assessed as antioxidants have shown therapeutic prospects in preclinical studies, clinical trial outcomes have been inadequate. Understanding the mechanisms through which antioxidants act, where, and when they are active may reveal a rational approach that leads to more tremendous pharmacological success. This review studies the associations between oxidative stress, redox signaling, and disease, the mechanisms through which oxidative stress can donate to pathology, the antioxidant defenses, the limits of their effectiveness, and antioxidant defenses that can be increased through physiological signaling, dietary constituents, and probable pharmaceutical interference. Prospective clinical applications of enzyme mimics and current progress in metal- and non-metal-based materials with enzyme-like activities and protection against chronic diseases have been discussed.</p><p><strong>Conclusion: </strong>This review discussed oxidative stress as one of the main causes of illnesses, as well as antioxidant systems and their defense mechanisms that can be useful in inhibiting these diseases. Thus, the positive and deleterious effects of antioxidant molecules used to lessen oxidative stress in numerous human diseases are discussed. The optimal level of vitamins and minerals is the amount that achieves the best feed benefit, best growth rate, and health, including immune efficiency, and provides sufficient amounts to the body.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":" ","pages":"151-167"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141731647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increase in the specificity of immunoassay methods by direct targeting different epitopes; sequential chain reactions. 通过直接针对不同的表位提高免疫测定方法的特异性;连续链反应。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/HAB-240019
Yasin Ahmadi, Hamid Ahmadi, Leili Aghebati-Maleki

Background: Immunoassay methods typically involve the use of antibodies, which are either labeled with an enzyme to generate a detectable product or directly tagged with a radioactive or fluorescent substrate.

Methods: One approach to enhance the specificity of immuno-detection methods is by employing a combination of different antibodies, such as primary and secondary.

Results: However, relying solely on one antibody targeting another may not offer the highest level of precision for improving immunoassay specificity; A novel strategy for enhancing the specificity of immunoassay techniques involves directly targeting different epitopes of an antigen.

Conclusions: This approach entails utilizing sequential chain reactions facilitated by distinct enzymes bound to various antibodies, each directed at specific epitopes on the antigen. Such an innovative method holds promise for advancing the specificity of immunoassay methods.

背景:免疫测定方法通常涉及抗体的使用,抗体或被酶标记以产生可检测的产物,或直接被放射性或荧光底物标记:方法:提高免疫检测方法特异性的一种方法是结合使用不同的抗体,如一抗和二抗:然而,仅仅依靠一种抗体靶向另一种抗体可能无法提供最高水平的精确度来提高免疫测定的特异性;一种提高免疫测定技术特异性的新策略是直接靶向抗原的不同表位:这种方法需要利用与各种抗体结合的不同酶促进连续链反应,每种酶都针对抗原上的特定表位。这种创新方法有望提高免疫测定方法的特异性。
{"title":"Increase in the specificity of immunoassay methods by direct targeting different epitopes; sequential chain reactions.","authors":"Yasin Ahmadi, Hamid Ahmadi, Leili Aghebati-Maleki","doi":"10.3233/HAB-240019","DOIUrl":"10.3233/HAB-240019","url":null,"abstract":"<p><strong>Background: </strong>Immunoassay methods typically involve the use of antibodies, which are either labeled with an enzyme to generate a detectable product or directly tagged with a radioactive or fluorescent substrate.</p><p><strong>Methods: </strong>One approach to enhance the specificity of immuno-detection methods is by employing a combination of different antibodies, such as primary and secondary.</p><p><strong>Results: </strong>However, relying solely on one antibody targeting another may not offer the highest level of precision for improving immunoassay specificity; A novel strategy for enhancing the specificity of immunoassay techniques involves directly targeting different epitopes of an antigen.</p><p><strong>Conclusions: </strong>This approach entails utilizing sequential chain reactions facilitated by distinct enzymes bound to various antibodies, each directed at specific epitopes on the antigen. Such an innovative method holds promise for advancing the specificity of immunoassay methods.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":" ","pages":"181-186"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142141755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of serum biomarkers level transforming growth factor-β and tumor necrosis factor-α with diabetic neuropathy. 血清生物标志物水平转化生长因子-β和肿瘤坏死因子-α与糖尿病神经病变的关系
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/HAB-240031
Dhifaf Abdulrhaman, Hayfaa Fahad, Nawar Khalil

Background: Many studies have examined the role of inflammation in the development of diabetic neuropathy (DPN).

Objective: Evaluate the relation of the serum level of Transforming Growth Factor-β and Tumor Necrosis Factor-α and development of diabetic peripheral neuropathy DPN.

Methods: In a case-control study, randomly selected 140 diabetic patients were included, the randomly selected patients were divided equally and matched into a case group who have diabetic peripheral neuropathy and diabetic neuropathy-free patients as a control group. For both groups whole blood sample was examined to compare for (TGF-β), and (TNF-α) levels determination by ELISA technique.

Results: The age of the study samples ranged from 25 to 80 years with a male ratio of 1.45:1 although the sex differences between both groups were not significant. The mean levels of (TNF-α) and (TGF-β) was significantly higher among cases group than that of controls group (254.86 ± 75.9 vs158.01 ± 50.600) for TNF-α and for TGF- β (312.85 ± 62.27 vs. 217.82 ± 52.95) respectively. Both TNF-α and TGF-β have high sensitivity and specificity in detection of DPN. The sensitivity of TNF-α was 95.7% and specificity of 61.4% area under the ROC curve (AUC) of 0.870 ± 0.029, while the sensitivity of TGF-β was 91.4%, and specificity of 67.1 with good area under the ROC curve (AUC) of 0.891 ± 0.026 (P=0.000).

Conclusions: TNF-α and TGF -β are significantly elevated levels in patients with DPN, these cytokines could be used as indicators for the development of DPN.

背景:许多研究都探讨了炎症在糖尿病神经病变(DPN)发生过程中的作用:许多研究都探讨了炎症在糖尿病神经病变(DPN)发生中的作用:评估血清中转化生长因子-β和肿瘤坏死因子-α的水平与糖尿病周围神经病变DPN发病的关系:在一项病例对照研究中,随机抽取 140 名糖尿病患者,将其平均分为患有糖尿病周围神经病变的病例组和无糖尿病周围神经病变的对照组。对两组患者的全血样本进行检测,通过 ELISA 技术比较(TGF-β)和(TNF-α)水平:研究样本的年龄从 25 岁到 80 岁不等,男女比例为 1.45:1,但两组样本的性别差异并不明显。病例组(TNF-α)和(TGF-β)的平均水平明显高于对照组(TNF-α为 254.86 ± 75.9 vs 158.01 ± 50.600,TGF- β为 312.85 ± 62.27 vs 217.82 ± 52.95)。TNF-α和TGF-β在检测DPN方面都具有较高的灵敏度和特异性。TNF-α的灵敏度为95.7%,特异性为61.4%,ROC曲线下面积(AUC)为0.870 ± 0.029;TGF-β的灵敏度为91.4%,特异性为67.1,ROC曲线下面积(AUC)为0.891 ± 0.026(P=0.000):结论:TNF-α和TGF-β在DPN患者中明显升高,这些细胞因子可作为DPN发病的指标。
{"title":"Association of serum biomarkers level transforming growth factor-β and tumor necrosis factor-α with diabetic neuropathy.","authors":"Dhifaf Abdulrhaman, Hayfaa Fahad, Nawar Khalil","doi":"10.3233/HAB-240031","DOIUrl":"10.3233/HAB-240031","url":null,"abstract":"<p><strong>Background: </strong>Many studies have examined the role of inflammation in the development of diabetic neuropathy (DPN).</p><p><strong>Objective: </strong>Evaluate the relation of the serum level of Transforming Growth Factor-β and Tumor Necrosis Factor-α and development of diabetic peripheral neuropathy DPN.</p><p><strong>Methods: </strong>In a case-control study, randomly selected 140 diabetic patients were included, the randomly selected patients were divided equally and matched into a case group who have diabetic peripheral neuropathy and diabetic neuropathy-free patients as a control group. For both groups whole blood sample was examined to compare for (TGF-β), and (TNF-α) levels determination by ELISA technique.</p><p><strong>Results: </strong>The age of the study samples ranged from 25 to 80 years with a male ratio of 1.45:1 although the sex differences between both groups were not significant. The mean levels of (TNF-α) and (TGF-β) was significantly higher among cases group than that of controls group (254.86 ± 75.9 vs158.01 ± 50.600) for TNF-α and for TGF- β (312.85 ± 62.27 vs. 217.82 ± 52.95) respectively. Both TNF-α and TGF-β have high sensitivity and specificity in detection of DPN. The sensitivity of TNF-α was 95.7% and specificity of 61.4% area under the ROC curve (AUC) of 0.870 ± 0.029, while the sensitivity of TGF-β was 91.4%, and specificity of 67.1 with good area under the ROC curve (AUC) of 0.891 ± 0.026 (P=0.000).</p><p><strong>Conclusions: </strong>TNF-α and TGF -β are significantly elevated levels in patients with DPN, these cytokines could be used as indicators for the development of DPN.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":" ","pages":"193-199"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eukaryotic ribosome display for antibody discovery: A review. 用于发现抗体的真核核糖体展示:综述。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/HAB-240001
Randy Chance, Angray Singh Kang

Monoclonal antibody biologics have significantly transformed the therapeutic landscape within the biopharmaceutical industry, partly due to the utilisation of discovery technologies such as the hybridoma method and phage display. While these established platforms have streamlined the development process to date, their reliance on cell transformation for antibody identification faces limitations related to library diversification and the constraints of host cell physiology. Cell-free systems like ribosome display offer a complementary approach, enabling antibody selection in a completely in vitro setting while harnessing enriched cellular molecular machinery. This review aims to provide an overview of the fundamental principles underlying the ribosome display method and its potential for advancing antibody discovery and development.

单克隆抗体生物制剂极大地改变了生物制药行业的治疗格局,这部分归功于杂交瘤法和噬菌体展示等发现技术的应用。虽然这些成熟的平台简化了迄今为止的开发过程,但它们依赖细胞转化来鉴定抗体的做法面临着与库多样化和宿主细胞生理限制有关的局限性。无细胞系统(如核糖体展示)提供了一种补充方法,它能在完全体外环境中选择抗体,同时利用丰富的细胞分子机制。本综述旨在概述核糖体展示法的基本原理及其在推进抗体发现和开发方面的潜力。
{"title":"Eukaryotic ribosome display for antibody discovery: A review.","authors":"Randy Chance, Angray Singh Kang","doi":"10.3233/HAB-240001","DOIUrl":"10.3233/HAB-240001","url":null,"abstract":"<p><p>Monoclonal antibody biologics have significantly transformed the therapeutic landscape within the biopharmaceutical industry, partly due to the utilisation of discovery technologies such as the hybridoma method and phage display. While these established platforms have streamlined the development process to date, their reliance on cell transformation for antibody identification faces limitations related to library diversification and the constraints of host cell physiology. Cell-free systems like ribosome display offer a complementary approach, enabling antibody selection in a completely in vitro setting while harnessing enriched cellular molecular machinery. This review aims to provide an overview of the fundamental principles underlying the ribosome display method and its potential for advancing antibody discovery and development.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":" ","pages":"107-120"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141093385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Salicylic Acid on the gene expression of FnbA and FnbB genes in Staphylococcus hominis. 水杨酸对人葡萄球菌 FnbA 和 FnbB 基因表达的影响
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/HAB-240023
Halah Ahmed Abdulqader, Zainab Hekmatt Abood

Background: Staphylococcus hominis is an opportunistic pathogen that expresses surface proteins, which are adhesive proteins that play a major role in biofilm formation. Biofilm is a protective layer that provides S. hominis bacteria with greater antibiotic resistance and promotes its adherence to biomedical surfaces, facilitating its entry into the bloodstream.

Objective: This research aimed to investigate the activity of Salicylic Acid (SA) and its effect on the gene expression of biofilm genes (FnbA and FnbB genes).

Methods: A total of 150 blood specimens were collected from patients. The specimens were cultured in broth media of the BacT/ALERT® system and subcultured on blood and chocolate agar. Bacteria were detected using the VITEK2 system. FnbA and FnbB genes were detected using PCR. The broth microdilution method performed the minimum inhibitory concentration (MIC) of Salicylic acid (SA) on S. hominis isolates with both genes. Detection of the gene expression levels of FnbA and FnbB genes was assessed using Real-Time PCR(RT-PCR).

Results: The results showed that out of the 150 specimens collected, 35 were S. hominis. The detection of S. hominis bacteria was performed by PCR amplification of two genes FnbA and FnbB and showed 100% and 17.14% of isolates were positive for genes FnbA and FnbB, respectively. The expression of FnbA and FnbB genes was decreased in samples treated with SA compared with untreated ones.

Conclusion: In conclusion, there is a significant impact of SA on the prevention of biofilm formation of S. hominis through the suppression of gene expression, specifically FnbA and FnbB. This could enhance susceptibility to antimicrobial treatments. However, more research is required to determine whether SA leads to the selection of resistant bacteria.

背景:人葡萄球菌是一种机会性病原体,它能表达表面蛋白,而表面蛋白是一种粘附蛋白,在生物膜形成过程中发挥着重要作用。生物膜是一种保护层,为人葡萄球菌提供了更强的抗生素耐药性,并促进其附着于生物医学表面,为其进入血液提供了便利:本研究旨在探讨水杨酸(SA)的活性及其对生物膜基因(FnbA 和 FnbB 基因)表达的影响:方法:共收集了 150 份患者血液标本。标本在 BacT/ALERT® 系统的肉汤培养基中培养,并在血液和巧克力琼脂上进行亚培养。使用 VITEK2 系统检测细菌。使用 PCR 检测 FnbA 和 FnbB 基因。肉汤微量稀释法测定水杨酸(SA)对带有这两种基因的人嗜血杆菌分离株的最低抑菌浓度(MIC)。采用实时 PCR(RT-PCR)技术检测 FnbA 和 FnbB 基因的表达水平:结果表明,在采集的 150 份标本中,有 35 份为人吸虫。通过对 FnbA 和 FnbB 两种基因进行 PCR 扩增,结果显示分别有 100%和 17.14%的分离株对 FnbA 和 FnbB 基因呈阳性。与未处理的样本相比,用 SA 处理的样本中 FnbA 和 FnbB 基因的表达量有所下降:总之,通过抑制基因(特别是 FnbA 和 FnbB)的表达,SA 对预防人乳头瘤病毒生物膜的形成有重要影响。这可能会提高对抗菌治疗的敏感性。不过,要确定 SA 是否会导致耐药细菌的产生,还需要进行更多的研究。
{"title":"Effect of Salicylic Acid on the gene expression of FnbA and FnbB genes in Staphylococcus hominis.","authors":"Halah Ahmed Abdulqader, Zainab Hekmatt Abood","doi":"10.3233/HAB-240023","DOIUrl":"10.3233/HAB-240023","url":null,"abstract":"<p><strong>Background: </strong>Staphylococcus hominis is an opportunistic pathogen that expresses surface proteins, which are adhesive proteins that play a major role in biofilm formation. Biofilm is a protective layer that provides S. hominis bacteria with greater antibiotic resistance and promotes its adherence to biomedical surfaces, facilitating its entry into the bloodstream.</p><p><strong>Objective: </strong>This research aimed to investigate the activity of Salicylic Acid (SA) and its effect on the gene expression of biofilm genes (FnbA and FnbB genes).</p><p><strong>Methods: </strong>A total of 150 blood specimens were collected from patients. The specimens were cultured in broth media of the BacT/ALERT® system and subcultured on blood and chocolate agar. Bacteria were detected using the VITEK2 system. FnbA and FnbB genes were detected using PCR. The broth microdilution method performed the minimum inhibitory concentration (MIC) of Salicylic acid (SA) on S. hominis isolates with both genes. Detection of the gene expression levels of FnbA and FnbB genes was assessed using Real-Time PCR(RT-PCR).</p><p><strong>Results: </strong>The results showed that out of the 150 specimens collected, 35 were S. hominis. The detection of S. hominis bacteria was performed by PCR amplification of two genes FnbA and FnbB and showed 100% and 17.14% of isolates were positive for genes FnbA and FnbB, respectively. The expression of FnbA and FnbB genes was decreased in samples treated with SA compared with untreated ones.</p><p><strong>Conclusion: </strong>In conclusion, there is a significant impact of SA on the prevention of biofilm formation of S. hominis through the suppression of gene expression, specifically FnbA and FnbB. This could enhance susceptibility to antimicrobial treatments. However, more research is required to determine whether SA leads to the selection of resistant bacteria.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":" ","pages":"139-149"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141322008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the impact of the genetic variant CXCR1 (rs2234671) in individuals with urinary tract infections. 调查遗传变异 CXCR1 (rs2234671) 对尿路感染患者的影响。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/HAB-230019
Hassan Hachim Naser, Mohanad Jawad Kadhim, Hazem Almhanna

Background: Urinary tract infections (UTIs) are currently posing a worldwide health concern by affecting millions of people. The genetic variant rs2234671 in the CXCR1-interleukin-8 receptor is closely related to a raised UTI risk.

Objectives: In this work, the impact of CXCR1 (rs2234671) on UTI individuals was examined.

Methods: The demographic features of 30 recurrent UTI patients and 20 controls were thoroughly investigated. Bacterial isolation and identification were performed by the implementation of cultural and biochemical methods. DNA extraction, purification of all samples from both patients and healthy people, and IL-8 rs2234671 (C/G) SNP genotyping using T-ARMS-PCR were performed. The significance of the results was evaluated by carrying out a statistical analysis.

Findings: The patient's average age was 34.63 ± 11.44 years, and controls averaged 30.30 ± 8.59 years (P= 0.156). No significant gender difference existed (P= 0.804). Escherichia coli (63.3%) was predominant, followed by Proteus mirabilis (26.7%), Enterococcus faecalis (23.3%), Klebsiella pneumoniae (10.0%), and Pseudomonas aeruginosa (20.0%). No significant association was found between bacterial species frequency, age, or sex. From the CXCR1 (rs2234671) frequency comparison, a higher GG genotype incidence in UTI patients than controls was extracted (26.7% vs. 15.0%), though not statistically significant. Risk analysis revealed that GG homozygous and C/G heterozygous genotypes were not UTI risk factors (OR = 2.47 and OR = 1.85, respectively). Moreover, the allele frequencies displayed no significant difference between the patients and controls (G allele: 66.7% vs. 66.7%; C allele: 33.3% vs. 33.3%).

Main conclusions: Although no significant association between CXCR1 (rs2234671) and UTI was found, the GG genotype may point to the increasing probability of UTI risk. Additional research is required to confirm and expand these conclusions.

背景:目前,尿路感染(UTI)影响着数百万人的健康,已成为一个世界性的健康问题。CXCR1-白细胞介素-8受体的遗传变异rs2234671与UTI风险的增加密切相关:本文研究了 CXCR1(rs2234671)对 UTI 患者的影响:方法:全面调查了 30 名复发性 UTI 患者和 20 名对照组的人口统计学特征。方法:对 30 名复发性 UTI 患者和 20 名对照组的人口特征进行了全面调查,并通过文化和生化方法对细菌进行了分离和鉴定。对患者和健康人的所有样本进行 DNA 提取、纯化,并使用 T-ARMS-PCR 对 IL-8 rs2234671 (C/G) SNP 进行基因分型。通过统计分析评估了结果的意义:患者的平均年龄为(34.63 ± 11.44)岁,对照组的平均年龄为(30.30 ± 8.59)岁(P= 0.156)。无明显性别差异(P= 0.804)。大肠埃希菌(63.3%)居多,其次是奇异变形杆菌(26.7%)、粪肠球菌(23.3%)、肺炎克雷伯菌(10.0%)和铜绿假单胞菌(20.0%)。细菌种类频率、年龄或性别之间没有发现明显的关联。从 CXCR1 (rs2234671) 频率比较中发现,UTI 患者的 GG 基因型发生率高于对照组(26.7% 对 15.0%),但无统计学意义。风险分析表明,GG 同源基因型和 C/G 杂合基因型不是 UTI 风险因素(OR = 2.47 和 OR = 1.85)。此外,患者和对照组的等位基因频率没有明显差异(G 等位基因:66.7% 对 66.7%;C 等位基因:33.3% 对 33.3%):主要结论:尽管未发现 CXCR1 (rs2234671) 与UTI 之间存在明显关联,但 GG 基因型可能会增加UTI 风险的概率。需要进行更多的研究来证实和扩展这些结论。
{"title":"Investigating the impact of the genetic variant CXCR1 (rs2234671) in individuals with urinary tract infections.","authors":"Hassan Hachim Naser, Mohanad Jawad Kadhim, Hazem Almhanna","doi":"10.3233/HAB-230019","DOIUrl":"10.3233/HAB-230019","url":null,"abstract":"<p><strong>Background: </strong>Urinary tract infections (UTIs) are currently posing a worldwide health concern by affecting millions of people. The genetic variant rs2234671 in the CXCR1-interleukin-8 receptor is closely related to a raised UTI risk.</p><p><strong>Objectives: </strong>In this work, the impact of CXCR1 (rs2234671) on UTI individuals was examined.</p><p><strong>Methods: </strong>The demographic features of 30 recurrent UTI patients and 20 controls were thoroughly investigated. Bacterial isolation and identification were performed by the implementation of cultural and biochemical methods. DNA extraction, purification of all samples from both patients and healthy people, and IL-8 rs2234671 (C/G) SNP genotyping using T-ARMS-PCR were performed. The significance of the results was evaluated by carrying out a statistical analysis.</p><p><strong>Findings: </strong>The patient's average age was 34.63 ± 11.44 years, and controls averaged 30.30 ± 8.59 years (P= 0.156). No significant gender difference existed (P= 0.804). Escherichia coli (63.3%) was predominant, followed by Proteus mirabilis (26.7%), Enterococcus faecalis (23.3%), Klebsiella pneumoniae (10.0%), and Pseudomonas aeruginosa (20.0%). No significant association was found between bacterial species frequency, age, or sex. From the CXCR1 (rs2234671) frequency comparison, a higher GG genotype incidence in UTI patients than controls was extracted (26.7% vs. 15.0%), though not statistically significant. Risk analysis revealed that GG homozygous and C/G heterozygous genotypes were not UTI risk factors (OR = 2.47 and OR = 1.85, respectively). Moreover, the allele frequencies displayed no significant difference between the patients and controls (G allele: 66.7% vs. 66.7%; C allele: 33.3% vs. 33.3%).</p><p><strong>Main conclusions: </strong>Although no significant association between CXCR1 (rs2234671) and UTI was found, the GG genotype may point to the increasing probability of UTI risk. Additional research is required to confirm and expand these conclusions.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":" ","pages":"9-18"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139713312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of physical exercise on inactivated COVID-19 vaccine antibody response in the elderly. 体育锻炼对老年人 COVID-19 灭活疫苗抗体反应的影响。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/HAB-230020
Ömer Şevgin, Songül Özer

Background: Physical exercise has been proposed as a new alternative to chemical adjuvants.

Objective: To investigate the relationship between regular exercise and post-vaccination antibody response in the elderly.

Methods: The study was conducted with the elderly over the age of 65. 30 participants we randomized into 2 groups and divided into exercise and control groups. The experimental group received a 12-week exercise program. The control group was followed up without any exercise. The day on which the second dose of the vaccine was administered to all participants was considered day 0. The antibody level in the serum samples was taken 15 days and 12 weeks after the vaccination. The antibody concentration was measured after the second dose of vaccination.

Results: The mean antibody level in the control group was 69.4 U/ml and 56.4 U/ml 15 days and 12 weeks after the second vaccination. The mean antibody level in the exercise group was 74 U/ml and 71.6 U/ml 15 days and 12 weeks after the second vaccination.

Conclusions: Regular exercise of light to moderate intensity may increase post-vaccination antibody response in the elderly. Therefore, exercise can be used as a behavioral adjuvant to improve the vaccine efficacy in the elderly.

背景:体育锻炼被认为是化学佐剂的新替代品:体育锻炼被认为是化学佐剂的新替代品:调查老年人定期锻炼与接种疫苗后抗体反应之间的关系:研究对象为 65 岁以上的老年人。我们将 30 名参与者随机分为两组,并将其分为运动组和对照组。实验组接受为期 12 周的锻炼计划。对照组不做任何运动。所有参与者接种第二剂疫苗的当天被视为第 0 天。在接种疫苗 15 天和 12 周后采集血清样本中的抗体水平。第二剂疫苗接种后测量抗体浓度:结果:接种第二剂疫苗 15 天和 12 周后,对照组的平均抗体水平分别为 69.4 U/ml 和 56.4 U/ml 。运动组的平均抗体水平在第二次接种后 15 天和 12 周分别为 74 U/ml 和 71.6 U/ml :结论:经常进行轻度至中度强度的运动可提高老年人接种疫苗后的抗体反应。因此,运动可作为一种行为佐剂来提高老年人的疫苗效力。
{"title":"Effect of physical exercise on inactivated COVID-19 vaccine antibody response in the elderly.","authors":"Ömer Şevgin, Songül Özer","doi":"10.3233/HAB-230020","DOIUrl":"10.3233/HAB-230020","url":null,"abstract":"<p><strong>Background: </strong>Physical exercise has been proposed as a new alternative to chemical adjuvants.</p><p><strong>Objective: </strong>To investigate the relationship between regular exercise and post-vaccination antibody response in the elderly.</p><p><strong>Methods: </strong>The study was conducted with the elderly over the age of 65. 30 participants we randomized into 2 groups and divided into exercise and control groups. The experimental group received a 12-week exercise program. The control group was followed up without any exercise. The day on which the second dose of the vaccine was administered to all participants was considered day 0. The antibody level in the serum samples was taken 15 days and 12 weeks after the vaccination. The antibody concentration was measured after the second dose of vaccination.</p><p><strong>Results: </strong>The mean antibody level in the control group was 69.4 U/ml and 56.4 U/ml 15 days and 12 weeks after the second vaccination. The mean antibody level in the exercise group was 74 U/ml and 71.6 U/ml 15 days and 12 weeks after the second vaccination.</p><p><strong>Conclusions: </strong>Regular exercise of light to moderate intensity may increase post-vaccination antibody response in the elderly. Therefore, exercise can be used as a behavioral adjuvant to improve the vaccine efficacy in the elderly.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":" ","pages":"19-24"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139713311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship of TNFα-238 G/A (rs 361525) genotypes with TNFα gene expression in liver and pancreas disorders in sample of beta thalassemia major adult Iraqi patients. 伊拉克重型地中海贫血成年患者样本中 TNFα-238 G/A (rs 361525) 基因型与肝脏和胰腺疾病中 TNFα 基因表达的关系。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/HAB-240022
Hawraa Allawi Luaibi, Bushra Jasim Mohammed

Background: Tumor necrosis factor-α (TNFα) is a crucial physiologic regulator of immune responses, and several disorders have been associated with its dysregulation.

Objective: This study aimed to understand TNFα gene expression in adult patients with liver and pancreas disorders and examine the impact of TNFα-238 genotypes on this population.

Methods: At the Ibn Al-Baladi Hospital in Baghdad, blood samples were collected from forty patients who were diagnosed with beta thalassemia together with pancreatic disease, forty patients who were diagnosed with thalassemia together with liver disorder, and forty patients who were diagnosed with thalassemia without pancreas or liver disorder. For the purpose of establishing a control group, forty samples were collected from persons who were of the same age and gender and seemed to be in good health. All of these individuals were deemed to be older than 18 years old. Through the utilization of real-time polymerase chain reaction (PCR), the level of TNF-α gene expression was investigated and assessed. The T-ARMS-PCR method was performed for detection and genotyping of TNFα-238 in thalassemia patients and healthy control samples.

Results: The result showed that TNF α gene expression assessment showed that group B (thalassemia patients with liver disorder) had higher folding than other groups while the lowest gene expression was in group D (as control group). Furthermore, the relationship between TNFα gene expressions folding with TNFα-238 genotypes in beta thalassemia major patients, discovered a considerable increase at GA genotype patients in TNFα gene expression level, followed by AA genotype compared to the GG genotype. Furthermore, the results of the current study showed an association between the presence of the mutant (A) allele whether heterozygous (GA) and homozygous (AA) with the TNF-α gene expression in thalassemia patients with liver and pancreatic disorders.

Conclusion: Based on the results, it can be concluded that there is a relationship between the presence of the mutant (A) allele, whether heterozygous (GA) or homozygous (AA) of TNF-α 238, and TNF-α gene expression in liver and pancreatic diseases as well as in patients with thalassemia.

背景:肿瘤坏死因子-α(TNF肿瘤坏死因子-α(TNFα)是免疫反应的重要生理调节因子,一些疾病与它的失调有关:本研究旨在了解肝脏和胰腺疾病成年患者的 TNFα 基因表达情况,并研究 TNFα-238 基因型对该人群的影响:方法:在巴格达的伊本-巴拉迪医院(Ibn Al-Baladi Hospital)采集了40名被诊断为β地中海贫血并发胰腺疾病的患者、40名被诊断为地中海贫血并发肝脏疾病的患者以及40名被诊断为地中海贫血但无胰腺或肝脏疾病的患者的血液样本。为了建立对照组,还从年龄和性别相同、健康状况良好的人身上采集了 40 份样本。所有这些人都被认为年龄在 18 岁以上。通过使用实时聚合酶链反应(PCR),对 TNF-α 基因表达水平进行了调查和评估。采用T-ARMS-PCR方法对地中海贫血患者和健康对照样本中的TNFα-238进行检测和基因分型:结果表明,TNFα基因表达评估结果显示,B组(地中海贫血肝病患者)的折叠率高于其他组,而D组(对照组)的基因表达最低。此外,β重型地中海贫血患者TNFα基因表达折叠与TNFα-238基因型的关系研究发现,与GG基因型相比,GA基因型患者的TNFα基因表达水平显著增加,其次是AA基因型。此外,本次研究结果表明,在患有肝脏和胰腺疾病的地中海贫血患者中,突变等位基因(A)的存在(无论是杂合型(GA)还是同源型(AA))都与 TNF-α 基因表达有关:根据研究结果,可以得出结论:TNF-α 238 的突变(A)等位基因(无论是杂合子(GA)还是同合子(AA))的存在与肝脏和胰腺疾病以及地中海贫血症患者的 TNF-α 基因表达之间存在关系。
{"title":"Relationship of TNFα-238 G/A (rs 361525) genotypes with TNFα gene expression in liver and pancreas disorders in sample of beta thalassemia major adult Iraqi patients.","authors":"Hawraa Allawi Luaibi, Bushra Jasim Mohammed","doi":"10.3233/HAB-240022","DOIUrl":"10.3233/HAB-240022","url":null,"abstract":"<p><strong>Background: </strong>Tumor necrosis factor-α (TNFα) is a crucial physiologic regulator of immune responses, and several disorders have been associated with its dysregulation.</p><p><strong>Objective: </strong>This study aimed to understand TNFα gene expression in adult patients with liver and pancreas disorders and examine the impact of TNFα-238 genotypes on this population.</p><p><strong>Methods: </strong>At the Ibn Al-Baladi Hospital in Baghdad, blood samples were collected from forty patients who were diagnosed with beta thalassemia together with pancreatic disease, forty patients who were diagnosed with thalassemia together with liver disorder, and forty patients who were diagnosed with thalassemia without pancreas or liver disorder. For the purpose of establishing a control group, forty samples were collected from persons who were of the same age and gender and seemed to be in good health. All of these individuals were deemed to be older than 18 years old. Through the utilization of real-time polymerase chain reaction (PCR), the level of TNF-α gene expression was investigated and assessed. The T-ARMS-PCR method was performed for detection and genotyping of TNFα-238 in thalassemia patients and healthy control samples.</p><p><strong>Results: </strong>The result showed that TNF α gene expression assessment showed that group B (thalassemia patients with liver disorder) had higher folding than other groups while the lowest gene expression was in group D (as control group). Furthermore, the relationship between TNFα gene expressions folding with TNFα-238 genotypes in beta thalassemia major patients, discovered a considerable increase at GA genotype patients in TNFα gene expression level, followed by AA genotype compared to the GG genotype. Furthermore, the results of the current study showed an association between the presence of the mutant (A) allele whether heterozygous (GA) and homozygous (AA) with the TNF-α gene expression in thalassemia patients with liver and pancreatic disorders.</p><p><strong>Conclusion: </strong>Based on the results, it can be concluded that there is a relationship between the presence of the mutant (A) allele, whether heterozygous (GA) or homozygous (AA) of TNF-α 238, and TNF-α gene expression in liver and pancreatic diseases as well as in patients with thalassemia.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":" ","pages":"67-74"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141093390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of SARS-Cov-2 neutralizing antibody among Sinopharm Vero Cell (BBIBP-CorV) vaccinated medical students. 评估接种国药Vero细胞(BBIBP-CorV)疫苗的医学生的SARS-Cov-2中和抗体。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/HAB-240029
Sony Khadka, Sanjib Mani Regmi, Nuwadatta Subedi, Arjun Poudel, Dhaka Ram Bhandari, Mitesh Karn, Shanti Pradhan, Prabin Shrestha

Background: Information regarding seropositivity and vaccine efficacy among medical students is scarce. This study aims to detect the status of SARS-CoV-2 neutralizing antibodies among the Sinopharm's Vero Cell (BBIBP-CorV) vaccinated medical students.

Materials and methods: A prospective, cross-sectional study was carried out among medical students of Gandaki Medical College Teaching Hospital, Pokhara, Nepal from March through August 2022. The level of SARS-CoV-2 serum- neutralizing IgG antibody was measured and its relation with participants' age and sex, duration of vaccination, and any comorbid condition was determined.

Results: A total of 110 medical students were included in the final analysis, the majority being females (65.5%) and the mean age is 23.1 ± 3.2 years. Most of the students (96.4%) had neutralizing antibodies against SARS-CoV-2. Among the 29 (26.36%) students who received a booster dose, the positivity rate was 100%. The mean IgG levels were 9.57 ± 9.58 μg/ml and 2.91 ± 2.47 μg/ml among students receiving an additional booster dose and among those not receiving it, respectively. In the cohort receiving a booster dose of the vaccine, the average value of neutralizing IgG antibodies was high. In contrast, the ones not receiving it, the titers were low and showed a declining trend.

Conclusion: Though the dose strategy of the Sinopharm vaccine is effective, booster vaccination may be an important strategy to ensure protection among medical students, who are at high risk of COVID-19 due to constant patient exposure during their training. Further studies should assess vaccine efficacy among individuals who received other vaccines as well.

背景:有关医学生血清阳性和疫苗效力的信息很少。本研究旨在检测接种了国药集团 Vero 细胞(BBIBP-CorV)疫苗的医学生中 SARS-CoV-2 中和抗体的状况:2022 年 3 月至 8 月,在尼泊尔博卡拉甘达基医学院教学医院的医学生中开展了一项前瞻性横断面研究。测量了 SARS-CoV-2 血清中和 IgG 抗体的水平,并确定了其与参与者的年龄、性别、接种疫苗的时间以及任何合并症的关系:共有 110 名医科学生参与了最终分析,其中大多数为女性(65.5%),平均年龄为 23.1 ± 3.2 岁。大多数学生(96.4%)体内有针对 SARS-CoV-2 的中和抗体。在接受强化免疫的 29 名学生(26.36%)中,阳性率为 100%。接受额外强化免疫和未接受额外强化免疫的学生的平均 IgG 水平分别为 9.57 ± 9.58 μg/ml 和 2.91 ± 2.47 μg/ml。在接种了强化疫苗的学生群中,中和 IgG 抗体的平均值较高。结论:结论:尽管国药集团疫苗的剂量策略是有效的,但加强接种可能是确保医学生保护的重要策略,因为医学生在培训期间经常接触病人,是 COVID-19 的高危人群。进一步的研究还应评估接种过其他疫苗的人接种疫苗的效果。
{"title":"Evaluation of SARS-Cov-2 neutralizing antibody among Sinopharm Vero Cell (BBIBP-CorV) vaccinated medical students.","authors":"Sony Khadka, Sanjib Mani Regmi, Nuwadatta Subedi, Arjun Poudel, Dhaka Ram Bhandari, Mitesh Karn, Shanti Pradhan, Prabin Shrestha","doi":"10.3233/HAB-240029","DOIUrl":"10.3233/HAB-240029","url":null,"abstract":"<p><strong>Background: </strong>Information regarding seropositivity and vaccine efficacy among medical students is scarce. This study aims to detect the status of SARS-CoV-2 neutralizing antibodies among the Sinopharm's Vero Cell (BBIBP-CorV) vaccinated medical students.</p><p><strong>Materials and methods: </strong>A prospective, cross-sectional study was carried out among medical students of Gandaki Medical College Teaching Hospital, Pokhara, Nepal from March through August 2022. The level of SARS-CoV-2 serum- neutralizing IgG antibody was measured and its relation with participants' age and sex, duration of vaccination, and any comorbid condition was determined.</p><p><strong>Results: </strong>A total of 110 medical students were included in the final analysis, the majority being females (65.5%) and the mean age is 23.1 ± 3.2 years. Most of the students (96.4%) had neutralizing antibodies against SARS-CoV-2. Among the 29 (26.36%) students who received a booster dose, the positivity rate was 100%. The mean IgG levels were 9.57 ± 9.58 μg/ml and 2.91 ± 2.47 μg/ml among students receiving an additional booster dose and among those not receiving it, respectively. In the cohort receiving a booster dose of the vaccine, the average value of neutralizing IgG antibodies was high. In contrast, the ones not receiving it, the titers were low and showed a declining trend.</p><p><strong>Conclusion: </strong>Though the dose strategy of the Sinopharm vaccine is effective, booster vaccination may be an important strategy to ensure protection among medical students, who are at high risk of COVID-19 due to constant patient exposure during their training. Further studies should assess vaccine efficacy among individuals who received other vaccines as well.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":" ","pages":"187-192"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141731646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Human Antibodies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1